Enveric Biosciences, Inc. (ENVB)
Score window: May. 30, 2025 to May. 29, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Apr. 28, 2026 | CORRESP | Neutral/Informational | Moderate | Enveric Biosciences, Inc. has submitted a request to the SEC for the acceleration of the effectiveness of their Registration Statement on Form S-3, which is set to be effective on… | Read Filing EDGAR |
| Apr. 27, 2026 | UPLOAD | Concern from SEC | Moderate | The SEC correspondence dated April 27, 2026, informs Enveric Biosciences, Inc. that their registration statement on Form S-3, filed on April 23, 2026, will not be reviewed. The SE… | Read Filing EDGAR |
| Feb. 17, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Enveric Biosciences, Inc. that they will not review the company's registration statement filed on February 10, 2026. The letter emphasizes that the res… | Read Filing EDGAR |
| Feb. 17, 2026 | CORRESP | Neutral/Informational | Moderate | Enveric Biosciences, Inc. has submitted a request for the acceleration of their Registration Statement on Form S-1, seeking to have it declared effective by the SEC on February 17… | Read Filing EDGAR |
| Dec. 8, 2025 | CORRESP | Neutral/Informational | Moderate | Enveric Biosciences, Inc. has submitted a request to the SEC for the acceleration of their Registration Statement on Form S-3, seeking to have it declared effective on December 8,… | Read Filing EDGAR |
| Sep. 30, 2025 | UPLOAD | Concern from SEC | Moderate | The SEC has communicated to Enveric Biosciences, Inc. that it will not review their registration statement filed on September 29, 2025. The letter emphasizes the company's respons… | Read Filing EDGAR |